ANG Lifesciences India Ltd Financial Ratios
ANG · Healthcare · Current price ₹37.75
P/E ratio
-3.5x
P/B ratio
0.9x
ROE
0.0%
ROCE
-3.9%
Debt / Equity
1.47
Dividend yield
2.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -3.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -3.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.47 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with ANG Lifesciences India Ltd's latest numbers.
ANG Lifesciences India Ltd profitability
ANG Lifesciences India Ltd generates a return on equity of 0.0% and a return on capital employed of -3.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.47 and a P/E of -3.5x, ANG Lifesciences India Ltd is moderately leveraged. Our overall business-quality score for the company is 2.6 / 10.
Understand the ratios
More on ANG Lifesciences India Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.